Skip to main content
# Title Department Research Year
101 Thiadiazine-2-thione derivatives as new cell- cycle inhibitors Department of Medicinal Chemistry 2023
102 Selective fluorescence turn-on detection of combination cisplatin–etoposide chemotherapy based on N-CDs/GSH-CuNCs nanoprobe† Department of Pharmaceutical Analytical Chemistry 2023
103 Novel fluoroquinolone hybrids as dual DNA gyrase and urease inhibitors with potential antibacterial activity: Design, synthesis, and biological evaluation Department of Pharmaceutical Organic Chemistry 2023
104 LIPID NANOPARTICLES TECHNOLOGY IN VACCINES; SHAPING THE FUTURE OF PROPHYLACTIC MEDICINE Department of Industrial Pharmacy 2023
105 Phytochemical Investigation, In silico/In vivo Analgesic, and Anti-inflammatory Assessment of the Egyptian Cassia occidentalis L. Department of Pharmacognosy 2023
106 Effective loading of incompatible drugs into nanosized vesicles: a strategy to allow concurrent administration of furosemide and midazolam in simulated clinical settings Department of Pharmaceutics 2023
107 Design, synthesis, and antiproliferative properties of new 1, 2, 3-triazole-carboximidamide derivatives as dual EGFR/VEGFR-2 inhibitors Department of Pharmaceutical Organic Chemistry 2023
108 Synthesis and characterization of magnetic Ag–Fe3O4@polymer hybrid nanocomposite systems with promising antibacterial application Department of Industrial Pharmacy 2023
109 New 1,3,4-Oxadiazole-Chalcone/Benzimidazole Hybrids as Potent Anti-proliferative Agents Department of Pharmaceutical Organic Chemistry 2022
110 Chitosan Nanoparticles for Meloxicam Ocular Delivery: Development, In Vitro Characterization, and In Vivo Evaluation in a Rabbit Eye Model Department of Pharmaceutics 2022